D081CC00001, PK study Olaparib in combination with Endocrine therapy

• Research type

  Research Study

• Full title

  An Open-Label, Non-randomised, Parallel Group, Multicentre, Phase I Study to Assess the Safety and the Effect of Olaparib at Steady State on the Pharmacokinetics of the Anti-hormonal Agents Anastrozole, Letrozole and Tamoxifen at Steady State, and the Effect of the Anti-hormonal Agents on Olaparib, Following Administration in Patients With Advanced Solid Cancer

• IRAS ID

  154402

• Contact name

  Elizabeth Ruth Plummer

• Contact email

  Ruth.Plummer@newcastle.ac.uk

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2014-000542-29

• Clinicaltrials.gov Identifier

  NCT02093351

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  14/NE/0147

• Date of REC Opinion

  9 Jul 2014

• REC opinion

  Further Information Favourable Opinion